13 Articles
13 Articles

Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders
Funding will support two Phase 2 clinical trials in alcohol and cocaine use disordersCompany has initiated Phase 2 study in alcohol use disorder and plans to initiate cocaine studies over the next yearJohn Wagner M.D., Ph.D. to join as Chief…


Testimonials. "I was taking coke with my coffee to wake up": their long way to not relapse
For decades, they have been addicted to hard drugs. In the EDVO centre in Val-d'Oise, dozens of residents weaned from their addictions learn to rebuild themselves for a year with old dependents. A device of self-help essential to avoid the risk of relapse.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage